Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BA and VLNC for Smoking Cessation
NCT02927847Phase 2Completed
- Start
- Feb 2017
- Primary completion
- May 2021
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD). Started Feb 2017; status: completed.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02927847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02927847.